Joseph M. Curry, MD, discusses the introduction of immune checkpoint inhibitors for the treatment of patients with head and neck cancers.
Joseph M. Curry, MD
Advertisement
Joseph M. Curry, MD, is a head and neck surgical oncologist at Jefferson Health.
Articles by Joseph M. Curry, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
2
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
3
Beyond SC Daratumumab: Emerging Therapeutic Approaches for Smoldering Myeloma
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5
